Search

Your search keyword '"Malherbe, Stephanus"' showing total 246 results

Search Constraints

Start Over You searched for: Author "Malherbe, Stephanus" Remove constraint Author: "Malherbe, Stephanus"
246 results on '"Malherbe, Stephanus"'

Search Results

2. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise

3. Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB)

4. Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research

5. Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study

6. Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis

7. RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

8. Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

9. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis

10. A novel aerosol collection method shows the cough aeromicrobiome of people with tuberculosis is phylogenetically distinct from respiratory tract specimens

11. Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis

13. Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

14. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

16. Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients

17. Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli

18. Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups

20. Host blood RNA signatures predict the outcome of tuberculosis treatment

22. High resolution imaging and five-year tuberculosis contact outcomes

23. Immunologic and vascular biomarkers of mortality in critical COVID-19 in a South African cohort

24. Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response

25. Accuracy of diabetes screening methods used for people with tuberculosis, Indonesia, Peru, Romania, South Africa/Precision des methodes de depistage du diabete utilisees pour les personnes atteintes de tuberculose en Afrique du Sud, en Indonesie, au Perou et en Roumanie/Precision de los metodos de diagnostico de diabetes utilizados en personas con tuberculosis en Indonesia, Peru, Rumania y Sudafrica

28. Impaired resolution of blood transcriptomes through tuberculosis treatment with diabetes comorbidity.

29. Optimising the yield from bronchoalveolar lavage on human participants in infectious disease immunology research

30. Diagnostic Performance of Host Blood Transcriptomic Signatures for Pulmonary Tuberculosis in a Multi-Cohort Study of Symptomatic Patients in Africa

31. Understanding the biology, morbidity and social contexts of adolescent tuberculosis: a prospective observational cohort study protocol (Teen TB)

32. cis-eQTL mapping of TB-T2D comorbidity elucidates the involvement of African ancestry in TB susceptibility

33. A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images

34. Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure

35. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment

36. Sildenafil, a Type-5 Phosphodiesterase Inhibitor, Fails to Reverse Myeloid-Derived Suppressor Cell-Mediated T Cell Suppression in Cells Isolated From Tuberculosis Patients

37. Targeted Gene Expression Profiling of Human Myeloid Cells From Blood and Lung Compartments of Patients With Tuberculosis and Other Lung Diseases

38. Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis

39. Author Correction: A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes

40. Additional file 2 of Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

41. Additional file 1 of Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

42. Additional file 3 of Cascade Immune Mechanisms of Protection against Mycobacterium tuberculosis (IMPAc-TB): study protocol for the Household Contact Study in the Western Cape, South Africa

45. Establishment of a Patient-Derived, Magnetic Levitation-Based, Three-Dimensional Spheroid Granuloma Model for Human Tuberculosis

47. Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

49. Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results.

50. Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial

Catalog

Books, media, physical & digital resources